MDT241220P72500
- 0.01
- -0.02-66.67%
Medtronic Newsroom
Goldman Sachs Adjusts Price Target on Medtronic to $83 From $84, Maintains Sell Rating
Morgan Stanley Reaffirms Their Buy Rating on Medtronic (MDT)
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating
Medtronic (MDT) Gets a Buy From Bank of America Securities
Medtronic Analyst Ratings
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $109
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $109
Barclays Adjusts Price Target on Medtronic to $109 From $105
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating
A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $87 to $105
Medtronic (MDT) Receives a Buy From RBC Capital
Medtronic Is Maintained at Overweight by Wells Fargo
Stifel Nicolaus Sticks to Their Hold Rating for Medtronic (MDT)
A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $90 to $105
Baird Maintains Neutral on Medtronic, Lowers Price Target to $93
Medtronic's Mixed Performance and Cautious Outlook Justifies Hold Rating
Medtronic Analyst Ratings
Analysts Conflicted on These Healthcare Names: Laboratory (LH) and Medtronic (MDT)
Barclays Sticks to Their Buy Rating for Medtronic (MDT)
Needham Remains a Hold on Medtronic (MDT)